ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

APPH Apontis Pharma AG

10.05
0.05 (0.50%)
20 Dec 2024 - Closed
Realtime Data

Apontis Pharma Financial Summary

The current APPH market cap is 85.43M. The company's latest EPS is EUR and P/E is N/A.

Year End 31 December 2023 2020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 40.32M54M57.35M38.05M
Operating Income -614k650k3.81M-15.12M
Net Income -1.18M-745k2.69M-11.3M
Year End 31 December 2023 2020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 29.69M54.13M59.85M57.46M
Total Liabilities 26.23M13.42M18.29M27.2M
Total Equity 3.46M40.71M41.57M30.26M

Cash Flow

Year End 31 December 2023 2020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)
Operating 1.45M3.43M11.02M-12.6M
Investing -777k-1.77M-2.68M-2.93M
Financing -2k20.12M-1.84M6M
Market Cap 85.43M
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 8.5M
Average Volume (1 week) 588
Average Volume (1 Month) 2.11k
52 Week Change 118.48%
52 Week High 10.15
52 Week Low 4.10
Spread (Intraday) 0.12 (1.19%)

Company Info

Company Name Apontis Pharma AG
Address alfred-nobel-stra��e 10
monheim 40789
Website https://apontis-pharma.de
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock